An exploratory analysis of on-treatment ctDNA measurement as a potential surrogate for overall survival for atezolizumab benefit in the OAK study D. R. Gandara,W. Zou,J. Jiang,S. Yaung,F. Fuhlbruck,J. Wu,M. Peterson,J. Palma,M. Ballinger, E. Peters,D. Shames,N. PatilAnnals of Oncology(2019)引用 2|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要